Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 1
211At-MABG in Adults With Advanced Neuroendocrine Cancers
Phase I dose escalation study of 211At-MABG in adults with advanced pheochromocytoma / paraganglioma (PPGL) or other NET-overexpressing cancers (as evidenced b…
PheochromocytomaParagangliomaNeuroendocrine Tumors+3 more
Estimated
~$10 – $6,250
University of PennsylvaniaNCT07661420
Phase 2
A Phase II Study of Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) in Patients With Progressing Metastatic Neuroendocrine Carcinomas (NECs)
This phase IIa trial compares the safety and effect of temozolomide combined with survivin long peptide vaccine (SurVaxM) to temozolomide alone in patients wit…
Digestive System Neuroendocrine NeoplasmLung Neuroendocrine NeoplasmMalignant Solid Neoplasm+1 more
Estimated
~$10 – $7,500
Roswell Park Cancer InstituteNCT06202066
Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms
This is a prospective observational multi-center pilot study of germline testing for participants receiving care at University of California participating loca…
Pancreatic Neuroendocrine Neoplasm
Estimated
~$10 – $675
University of California, San FranciscoNCT05746182